Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 4 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.
Haematologica. 2021 Sep 1;106(9):2458-2468. doi: 10.3324/haematol.2020.260224.
Haematologica. 2021.
PMID: 32732363
Free PMC article.
Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
Kolnagou A, Yazman D, Economides C, Eracleous E, Kontoghiorghes GJ.
Kolnagou A, et al.
Hemoglobin. 2009;33(5):312-22. doi: 10.3109/03630260903213231.
Hemoglobin. 2009.
PMID: 19814677
Item in Clipboard
Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions.
Kontoghiorghes GJ, Efstathiou A, Kleanthous M, Michaelides Y, Kolnagou A.
Kontoghiorghes GJ, et al. Among authors: kolnagou a.
Hemoglobin. 2009;33(5):386-97. doi: 10.3109/03630260903217141.
Hemoglobin. 2009.
PMID: 19814684
Item in Clipboard
Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone.
Telfer PT, Warburton F, Christou S, Hadjigavriel M, Sitarou M, Kolnagou A, Angastiniotis M.
Telfer PT, et al. Among authors: kolnagou a.
Haematologica. 2009 Dec;94(12):1777-8. doi: 10.3324/haematol.2009.009118. Epub 2009 Oct 8.
Haematologica. 2009.
PMID: 19815834
Free PMC article.
No abstract available.
Item in Clipboard
Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. experience from a Cyprus model and its use as a paradigm for future applications.
Kolnagou A, Kontoghiorghes GJ.
Kolnagou A, et al.
Hemoglobin. 2009;33(5):287-95. doi: 10.3109/03630260903212043.
Hemoglobin. 2009.
PMID: 19814674
Item in Clipboard
Cite
Cite